One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v126.23.59.59
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 7 |
Affiliation: Guy's and St Thomas' NHS Foundation Trust, University of Florence, Délégation Paris 7, Hôpital Saint-Louis, Université Paris Cité, Leipzig University, Medical University of Vienna, Cliniques Universitaires Saint-Luc, de Duve Institute, University of Barcelona, Incyte (United States), Novartis (France), Novartis (Switzerland), Ospedale Papa Giovanni XXIIILong-Term Efficacy and Safety in COMFORT-II, a Phase 3 Study Comparing Ruxolitinib with Best Available Therapy for the Treatment of Myelofibrosis: 5-Year Final Study Results
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
